The House legislation sets up a special trust fund for comparative effectiveness research, which is good. But it appropriates just $300 million over the next three years, and then $375 million a year thereafter. That's significantly less than the $1.1 billion in the stimulus act (that's over 18 months) and less than the $4-5 billion-per-year program some analysts were hoping for.